ACTN4 and lung carcinoma: When comparing lung cancer patients with low expression of ACTN4 to those with high expression, the Kaplan‒Meier Plotter database (http://kmplot.com/analysis/) revealed that the former had a better prognosis and a longer survival period (Figure 4D).